What is the main business of Stethome?

The main business activity of Stethome focuses on manufacture of other medical instruments and supplies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 18, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Winogrady 18A, 61-663 Poznań.

Who is on the management board?

The management board consists of: Paweł Andrzej Elbanowski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 653,050 (approx. $176,405).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the company generated total revenue of $267,112, representing a decrease of 41.6% compared to 2024.

No, the company recorded a net loss of $364,984 in 2025. For comparison, in 2024 the loss was $1,036,159, meaning the company reduced its loss by 64.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $210,336 in 2025, representing 39% of all operating expenses.

Stethomesp. z o.o.

Manufacture of other medical instruments and supplies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-05-18

Share capital

653 050,00 PLN

Activity description

Stethome is a company that offers an intelligent home stethoscope designed to detect distinctive sounds related to respiratory health conditions such as bronchitis, pneumonia, and asthma. Their product utilizes AI to identify abnormal sounds and measure important physiological parameters, aiding in the swift and accurate detection of symptoms for effective treatment.

Registered address

ul. Winogrady 18A, 61-663 Poznań, Poland

Website

stethome.com

Electronic delivery address

AE:PL-72274-35423-VEGRU-15

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 267.11kMedianUSD 848.96kAverageUSD 8.35m

Net profit

This companyUSD -364.98kMedianUSD 20.21kAverageUSD 574.87k

Operating costs

This companyUSD 534.74kMedianUSD 663.86kAverageUSD 7.41m

Assets

This companyUSD 1.38mMedianUSD 974.48kAverageUSD 6.92m

Industry

Bank accounts

Registered as a VAT taxpayer on 2015-05-30. Active

mBank
55 1140 1010 0000 4456 7400 1013
mBank
88 1140 1010 0000 4456 7400 1001
mBank
28 1140 1010 0000 4456 7400 1014

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

16 public aid cases recorded, with a total value of $4,632,505.

Grant date	Purpose	Gross amount	Granting body
Feb 12, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$1,135$1,135	Marszałek Województwa Wielkopolskiego
Jun 19, 2023	Aid for SME access to finance — risk finance aid	$399.5K$399,457	Dyrektor Narodowego Centrum Badań i Rozwoju
Nov 17, 2020	Aid for research and development projects: industrial research	$862.1K$862,117	Dyrektor Narodowego Centrum Badań i Rozwoju

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Paweł Andrzej Elbanowski — President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Supervisory board

Artur Grzegorz Banach — Supervisory Board Member

Wojciech Fedorowicz — Supervisory Board Member

Grzegorz Pindur — Supervisory Board Member

Magdalena Świergiel Pindur — Supervisory Board Member

Mateusz Rawecki — Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Dalpo Poland sp. z o.o.	2,937	$39,667.75	22.4868%
Integrale It sp. z o.o.	2,023	$27,323.07	15.4889%
TDJ S.A.	3,230	$43,625.07	24.7301%
Others	4,871	$65,788.76	37.2942%

Beneficial owners

Person	Rights
Paweł Andrzej Elbanowski (39)	Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5).

Competitors

Name	Revenue	Website
Si-Curasp. z o.o.	$1,631,852.12	si-cura.pl
Zakład Doświadczalny Echo-SonS.A.	$1,170,419.52	echoson.com.pl
Pulmeqsp. z o.o.	$1,126,185.54	pulmeq.com
Implaisp. z o.o.	$661,746.96	implai.com
ClebreS.A.	$87,678.59	clebre.com
UnitedmedP.S.A.	$79,858.73	united-med.pl
Milton EssexS.A.	$40,863.48	miltonessex.eu
Smart Labssp. z o.o.	$32,047.41	smart-labs.pl

Change history

Date	Event
2026-04-14	Share capital change (87,500.00 PLN → 653,050.00 PLN)
2026-04-14	PKD change (Removed: 32.50.Z; Added: 32.50.B)
2022-01-24	Share capital change (86,300.00 PLN → 87,500.00 PLN)
2021-04-30	Share capital change (81,950.00 PLN → 86,300.00 PLN)
2020-11-30	Share capital change (71,350.00 PLN → 81,950.00 PLN)

FAQ

Last updated: 2026-07-23